Ferroptosis-centered Disease Response Information
General Information of the Disease (ID: DIS00089)
Name |
Peripheral retinal degeneration
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: 9B78
|
Full List of Target(s) of This Ferroptosis-centered Disease
Unspecific Target
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
Responsed Disease | Peripheral retinal degeneration [ICD-11: 9B78] | |||
Responsed Drug | Sodium iodate | Investigative | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Glutathione metabolism | hsa00480 | |||
Cell Process | Cell ferroptosis | |||
In Vitro Model | ARPE-19 cells | Normal | Homo sapiens | CVCL_0145 |
HT-29 cells | Colon adenocarcinoma | Homo sapiens | CVCL_0320 | |
SH-SY5Y cells | Neuroblastoma | Homo sapiens | CVCL_0019 | |
Jurkat cells | T acute lymphoblastic leukemia | Homo sapiens | CVCL_0065 | |
Response regulation | Sodium iodate (SI) is a widely used oxidant for generating retinal degeneration models by inducing the death of retinal pigment epithelium (RPE) cells. SI depletes GSH, increases ROS, releases labile iron, and boosts lipid damage, which in turn results in ferroptosis in ARPE-19 cells. | |||